Copertina

Dupilumab‐Associated Ocular Surface Disease in Paediatric Atopic Dermatitis Patients: Results From the BioDay Registry

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Lisa P. van der Rijst, Chantal M. van Luijk, Sara van der Kamp, Nicolaas P. A. Zuithoff, Joke H. de Boer, Marjolein S. de Bruin‐Weller, Marlies de Graaf
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Clinical & Experimental Allergy
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Complementary Analysis of Local and Systemic Effects of Dupilumab in Paediatric AD Using Tape Strips and Serum
di: Lisa P. van der Rijst, et al.
Pubblicazione: (2025)

Dupilumab induces a significant decrease of food specific immunoglobulin E levels in pediatric atopic dermatitis patients
di: Lisa P. van der Rijst, et al.
Pubblicazione: (2024)

Ocular surface disease in pediatric patients with moderate‐to‐severe atopic dermatitis
di: Lisa P. van der Rijst, et al.
Pubblicazione: (2025)

Translating 6‐year trial safety data of upadacitinib in atopic dermatitis into clinical practice
di: Lian F. van der Gang, et al.
Pubblicazione: (2026)

Reply to Sujoy Khan
di: Lisa P. van der Rijst, et al.
Pubblicazione: (2024)

Addressing potential bias when assessing safety of biologics and JAK inhibitors in atopic dermatitis
di: Lian F. van der Gang, et al.
Pubblicazione: (2026)

Ocular surface disease in moderate‐to‐severe atopic dermatitis patients and the effect of biological therapy
di: Roselie Achten, et al.
Pubblicazione: (2024)

Tralokinumab Treatment in Adult Atopic Dermatitis Patients: 28‐Week Evaluation of Clinical Effectiveness, Safety, Serum Proteins and Total IgE Levels
di: Coco Dekkers, et al.
Pubblicazione: (2024)

Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions
di: Marjolein S. de Bruin‐Weller, et al.
Pubblicazione: (2025)

Reassuring evidence on infection risk with dupilumab in atopic dermatitis: Lessons from real‐world evidence
di: Lian F. van der Gang, et al.
Pubblicazione: (2025)

Type 2 Immune‐Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients
di: Coco Dekkers, et al.
Pubblicazione: (2024)

Calibrated ages of Lappmyran (LPM) peat core from Sweden
di: van der Linden, Marjolein
Pubblicazione: (2021)

Geochemistry of Saxnas Mosse (SNM) peat core from Sweden
di: van der Linden, Marjolein
Pubblicazione: (2021)

Age determination of Lappmyran (LPM) peat core from Sweden
di: van der Linden, Marjolein
Pubblicazione: (2021)

Geochemistry of Lappmyran (LPM) peat core from Sweden
di: van der Linden, Marjolein
Pubblicazione: (2021)

Calibrated ages of Saxnas Mosse (SNM) peat core from Sweden
di: van der Linden, Marjolein
Pubblicazione: (2021)

Age determination of Saxnas Mosse (SNM) peat core from Sweden
di: van der Linden, Marjolein
Pubblicazione: (2021)

Dupilumab‐Associated Ocular Surface Disease in Pediatric Atopic Dermatitis: A Single‐Center Asian Experience
di: Amanda Xin Yi Yap, et al.
Pubblicazione: (2024)

Upadacitinib for Refractory Paediatric Atopic Dermatitis: A Real‐World Study on Effectiveness and Safety in Dupilumab Nonresponders
di: Mutong Zhao, et al.
Pubblicazione: (2024)

Dupilumab's Real‐World Efficacy and Safety Across Age Groups for Children and Adolescents With Paediatric Atopic Dermatitis
di: Paul Sun Woo Kim, et al.
Pubblicazione: (2026)

Motor Skill Learning in Groups: Some Proposals for Applying Implicit Learning and Self-Controlled Feedback
di: John van der Kamp
Pubblicazione: (2015)

Combination Therapy With Upadacitinib and Dupilumab for Severe Atopic Dermatitis
di: Amaia Barrutia‐Etxebarria, et al.
Pubblicazione: (2025)

Sensory Quality of Macadamia Nut Butter: Effects of Kernel Grade and Maturity
di: Tarryn Amber Ohlsson, et al.
Pubblicazione: (2025)

Correction to “Higher Prevalence of Dupilumab‐Induced Ocular Adverse Events in Atopic Dermatitis Compared to Asthma: A Daily Practice Analysis”
Pubblicazione: (2026)

Hypergraphs and Lotka-Volterra systems with linear Darboux polynomials
di: van der Kamp, Peter H.
Pubblicazione: (2024)

Characteristics and Risk Factors of Dupilumab‐Associated Head and Neck Dermatitis in Patients With Atopic Dermatitis
di: Zifan Li, et al.
Pubblicazione: (2026)

Reimagining Social Value to Consider the Environment: How Should We Judge the Magnitude of Benefits in Health Research?
di: Bridget Pratt, et al.
Pubblicazione: (2025)

Entanglement in von Neumann Algebraic Quantum Information Theory
di: van Luijk, Lauritz
Pubblicazione: (2025)

Energy-limited quantum dynamics
di: van Luijk, Lauritz
Pubblicazione: (2024)

Concordance Between Patient‐ and Physician‐Reported Improvement With Dupilumab in Atopic Dermatitis
di: Geena Conde, et al.
Pubblicazione: (2026)

Dupilumab in Combination With JAK Inhibitor for Refractory Moderate‐to‐Severe Atopic Dermatitis
di: Xiaoting Song, et al.
Pubblicazione: (2024)

Real‐World Experience of Dupilumab in Children and Adolescents With Atopic Dermatitis in Argentina
di: Margarita Larralde, et al.
Pubblicazione: (2025)

Long‐Term Safety and Efficacy of Dupilumab in Pediatric Atopic Dermatitis Patients
di: Hilla Bauch-Eigner, et al.
Pubblicazione: (2025)

Real‐World Efficacy and Safety of Dupilumab for Atopic Dermatitis in the Israeli Population
di: Raz Tshuva, et al.
Pubblicazione: (2025)

Patient‐Reported Outcomes Selected by Paediatric Patients With Atopic Dermatitis in the Aiming High in Eczema/Atopic Dermatitis Approach
di: Yuji Fujita, et al.
Pubblicazione: (2025)

Severe Allergic Contact Dermatitis to Hair Dye in a Patient With Atopic Dermatitis During Dupilumab Therapy
di: Alessandra Chiei Gallo, et al.
Pubblicazione: (2025)

Interchanging Biosimilars Using Proteomics
di: Piet H. van der Graaf, et al.
Pubblicazione: (2025)

Progress in Clinical Pharmacology in China: An Ongoing Evolution
di: Liang Zhao, et al.
Pubblicazione: (2025)

Weaning off ThoroughQTStudies
di: Mai Mehanna, et al.
Pubblicazione: (2024)

Performances of Peace: Utrecht 1713
di: Onnekink, D., et al.
Pubblicazione: (2016)